South Carolina hospitals aren’t required to disclose measles-related admissions. That leaves doctors in the dark. South Carolina doesn’t require hospitals to report when they admit patients with ...

FDA hones in on antidepressants and RSV prevention; SCOTUS pulls the plug on Trump’s tariffs; GLP-1 turbulence dents Novo’s forecast.

FDA truncates drug approval process; Makary pushes for more OTC drugs; Inside the rocky ride for Recursion Pharmaceuticals.

​​For FY2026, Dentsu is guiding for another year of modest top‑line expansion and disciplined margins. It forecasts group ...

The Congressional Budget Office told lawmakers in December 2024 that not extending the enhanced subsidies would cause 2.2 ...

As more states enact laws that regulate how AI is used in healthcare marketing, pharma marketers will need to build guardrails around transparency, bias and human-in-the-loop.

NIH director to temporarily lead CDC; FDA switches up on Moderna vaccine; Trump officials tried to make peace with pharma; The mysterious symptom is popping up in some GLP-1 users.

Is AstraZeneca on track to meet 2030 revenue target?; CSL CEO Paul McKenzie retires; Epstein files reveal deeper ties to ...

It sounds like something from a science fiction novel, but Alabama officials’ plan to use robots to improve care for rural pregnant women and their babies is real.

Danaher Corp. entered into a definitive agreement to acquire Masimo in an all-cash transaction valued at approximately $9.9 billion. Madrigal Pharmaceuticals signed an exclusive global license ...

The bill, introduced by Sens. Rick Scott and Kirsten Gillibrand, follows a bipartisan investigation that cited ProPublica’s ...

Vicks took the top spot ahead of Rinvoq, Skyrizi and Tremfya, which continue to be the top spenders on national TV pharma ads.